Gottlieb Urges Transition to Abuse-Deterrent Opioid Formulations

Drug Industry Daily
A A
The FDA strongly supports transitioning the opioid painkiller market toward abuse-deterrent formulations, Commissioner Scott Gottlieb told a Senate committee examining the abuse epidemic.

To View This Article:

Login

Subscribe To Drug Industry Daily